C12N 2840/002
Controllable or inducible
Official title: controllable or inducible
C12N2840/002 (Controllable or inducible) appears on 47 US grants and 103 published applications in this corpus.
Search patents in C12N- Granted patents
- 47
- Published applications
- 103
- Assignees
- 75
- Inventors
- 225
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 2 |
| 2014 | 2 | 1 |
| 2015 | 2 | 6 |
| 2016 | 3 | 1 |
| 2017 | 3 | 6 |
| 2018 | 1 | 8 |
| 2019 | 2 | 7 |
| 2020 | 3 | 8 |
| 2021 | 5 | 6 |
| 2022 | 5 | 16 |
| 2023 | 1 | 7 |
| 2024 | 4 | 11 |
| 2025 | 5 | 9 |
| 2026 | 7 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Live attenuated non-transmissible vaccines7 Jul 2026US 12,674,131 B2University of Maryland, Baltimore
- Univariant extrinsic initiator control system for microbes and an in vitro assembly of large recombinant DNA molecules from multiple components2 Jun 2026US 12,644,126 B2Massachusetts Institute of Technology
- Plasmid addiction system to drive desired gene expression12 May 2026US 12,624,363 B2Sumitomo Chemical Company, Limited
- Protein crystal production method and crystalline structure analysis method14 Apr 2026US 12,600,999 B2Institute of Science Tokyo
- Cells for enhanced production of adeno-associated virus17 Mar 2026US 12,577,539 B2The Regents of the University of California
- Trigger-inducible mrna circularization23 Jul 2026US 2026/0209789 A1Westlake University
- Inducible promoters11 Jun 2026US 2026/0159847 A1Worcester Polytechnic Institute
- Adjustable gene therapy28 May 2026US 2026/0144895 A1Remedium Bio, Inc.
- Probiotic lactobacillus strain compositions and applications therefor including for leaky gut and inflammation21 May 2026US 2026/0137736 A1BiomEdit, Inc.
- Compositions and methods for virotherapy26 Feb 2026US 2026/0053948 A1Yeda Research and Development Co. Ltd.
Most cited
By later US patents
- D-amino acid-inducible gene expression system for Rhodosporidium and Rhodotorula9US 10,081,812 B2Temasek Life Sciences Laboratory Limited · 2018
- Use of suppressor tRNA's to regulate cytotoxicity during the production of recombinant gene products8US 6,586,208 B2Cell Genesys, Inc. · 2003
- Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells7US 11,471,494 B2Synlogic Operating Company, Inc. · 2022
- Biocontrol7US 9,487,801 B2Oxitec Limited · 2016
- Synthetic transcriptional control elements and methods of generating and using such elements7US 9,593,338 B2The Regents of the University of California · 2017